What is Tribenzor?
Tribenzor is a blood pressure prescription medication containing olmesartan medoxomil, hydrochlorothiazide and amlodipine. The medication was designed to treat hypertension or high blood pressure by improving blood flow, while stopping the blood vessels from being constricted. It was researched, manufactured and launched by the drug company, Daiichi Sankyo Inc., in 2010.
Spruce-Like Enteropathy and Tribenzor
By 2012, Tribenzor was already being linked to an intestinal problem called sprue-like enteropathy, which causes extreme weight loss and chronic diarrhea, just to name a few of its side-effects. It was not until mid July 2013 that the Food and Drug Administration (FDA) finally decided to issue a warning concerning the link Tribenzor had to sprue-like enteropathy.
Celiac Disease and Tribenzor
Sprue-like enteropathy is often difficult to identify because its symptoms resemble those for celiac disease, which is a disorder of the intestine that interferes with the ability of the body to use food correctly. Symptoms associated with celiac disease include:
- chronic diarrhea;
- abdominal bloating and pain;
- weight loss;
- foul-smell, pale or fatty stool.
Celiac disease is relatively easy to handle, as avoiding gluten can help to relieve it, but this is not so with sprue-like enteropathy caused by Tribenzor, where the only remedy available is to stop taking the drug. If you fail to stop taking Tribenzor you risk the chance of getting kidney failure which could have the following symptoms:
- problems with urinating;
- feet and legs swelling up;
- reduction in appetite;
- feelings of confusion, anxiety, restlessness and tiredness;
- back pain.
Apart from kidney failure and sprue-like enteropathy, there are other alarming side-effects that are possible which include:
- blood in the urine;
- damage to the muscles;
- irregular heartbeat;
- elevated levels of uric acid found in the blood;
- allergic reactions that could threaten life;
- giant hives
- Lowering of blood pressure.
$39 Million Paid Out By Daiichi Sankyo
It is not just the question of misleading the general public about the safety of Tribenzor. Daiichi Sankyo had to pay $39 million to Medicaid and the U.S. government for settling allegations that it was paying kickbacks to physicians who were prepared to prescribe Tribenzor to their patients.
How to Make a Claim For Tribenzor Side-Effects
When you are inflicted with high blood pressure you neither wanted nor asked for, you will typically be on the lookout for a drug which will heal your symptoms and put you back on the road. Tribenzor is highly recommended by your physician. You take it willingly without knowing that it is going to cause you to be even more sick, even to the point that you will be unable to return to normal life.
You may be entitled to personal injury compensation for damage done by a drug that the drug company failed to warn you about. You may receive compensation for medical expenses, lost of earnings, pain suffering, and other Tribenzor related damages. Call The Dixon Injury Firm today to discuss your Tribenzor lawsuit at 855-55-BAD-DRUG.
Latest posts by Christopher Dixon (see all)
- Third Jury Awards More Than $70 Million in Talcum Powder Case - October 28, 2016
- Johnson & Johnson’s Link To Ovarian Cancer - June 24, 2016
- Stryker Hip Implant Lawsuits Are Not Over Yet - June 3, 2016